SOR102

· Sorriso Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SOR102, covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis [Phase 1]

See pricing